Execution of apoptosis: Converging or diverging pathways?

Biological Chemistry

Volumn 380, Issue 9, 1999, Pages 1035-1040

  Nicotera, Pierluigi ^a   Leist, Marcel ^a   Single, Barbara ^a   Volbracht, Christiane ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

Apoptosis; ATP; Caspases; Neurodegeneration

Indexed keywords

CASPASE; CASPASE INHIBITOR; TRIPEPTIDE;

APOPTOSIS; CELL CULTURE; CELL DAMAGE; CELL ENERGY; CELL METABOLISM; CYTOLYSIS; ENZYME ACTIVATION; HUMAN; INFLAMMATION; NECROSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ADENOSINE TRIPHOSPHATE; ANIMALS; APOPTOSIS; CASPASES;

EID: 0032881768     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.1999.129     Document Type: Review

References (50)

1. Adjei, P.N., Kaufmann, S.H., Leung, W.-Y., Mao, F., and Gores, G.J. (1996). Selective induction of apoptosis in Hep 3B cells by toposiomerase I inhibitors: evidence for a protease-dependent pathway that does not activate cysteine protease P32. J. Clin. Invest. 98, 2588-2596.
2. Ankarcrona, M., Dypbukt, J.M., Bonfoco, E., Zhivotovsky, B., Orrenius, S., Lipton, S.A., and Nicotera, P. (1995). Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15, 961-973.
3. Borner, C., and Monney, L. (1999). Apoptosis without caspases: an inefficient molecular guillotine? Cell Death & Diff. 6, 497-507.
4. Carter, R.J., Lione, L.A., Humby, T., Mangiarini, L., Mahal, A., Bates, G.P., Dunnett, S.B., and Morton, A.J. (1999). Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J. Neurosci. 19, 3248-3257.
5. Chapman, P.F., White, G.L., Jones, M.W., Cooper-Blacketer, D., Marshall, V.J., Irizarry, M., Younkin, L., Good, M.A., Bliss, T.V., Hyman, B.T., Younkin, S.G., and Hsiao, K.K. (1999). Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat. Neurosci. 2, 271-276.
6. Charriaut-Marlangue, C., Aggoun-Zouaoui, D., Represa, A., and Ben-Ari, Y. (1996). Apoptotic features of selective neuronal death in ischemia, epilepsy and gp120 toxicity. Trends Neurosci. 19, 109-114.
7. Fink, K., Zhu, J., Namura, S., Shimizu-Sasamata, M., Endres, M., Ma, J., Dalkara, T., Yuan, J., and Moskowitz, M.A. (1998). Prolonged therapeutic window for ischemic brain damage caused by delayed caspase activation. J. Cereb. Blood Flow Metab. 18, 1071-1076.
8. Forloni, G., Angeretti, N., Chiesa, R., Monzani, E., Salmona, M., Bugiani, O., and Tagliavini, F. (1993). Neurotoxicity of a prion protein fragment. Nature 362, 543-546.
9. Forloni, G., Bugiani, O., Tagliavini, F., and Salmona, M. (1996). Apoptosis-mediated neurotoxicity induced by beta-amyloid and PrP fragments. Mol. Chem. Neuropathol. 28, 163-171.
10. Green, D., and Kroemer, G. (1998). The central executioners of apoptosis: caspases or mitochondria? Trends Cell Biol. 8, 267-271.
11. Grimm, L.M., Goldberg, A.L., Poirier, G.G., Schwartz, L.M., and Osborne, B.A. (1996). Proteasomes play an essential role in thymocyte apoptosis. EMBO J. 15, 3835-3844.
12. Hansson, O., Petersen, A., Leist, M., Nicotera, P., Castilho, R.F., and Brundin, P. (1999). Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity. Proc. Natl. Acad. Sci. USA, 96, 8727-8732.
13. Hirsch, T., Marchetti, P., Susin, S.A., Dallaporta, B., Zamzami, N., Marzo, I., Geuskens, M., and Kroemer, G. (1997). The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene 15, 1573-1581.
14. Jaattela, M., Wissing, D., Kokholm, K., Kallunki, T., and Egeblad, M. (1998). Hsp70 exerts its anti-apoptotic function downstream of caspase-3-like proteases. EMBO J. 17, 6124-6134.
15. Johnston, J.A., Ward, C.L., and Kopito, R.R. (1998). Aggresomes: a cellular response to misfolded proteins. J. Cell Biol. 143, 1883-1898.
16. Kerr, J.F., Wyllie, A.H., and Currie, A.R. (1972). Apoptosis: A basic biological phenomenon with wide ranging implications in tissue kinetics. Br. J. Cancer 26, 239-247.
17. Kim, M., Lee, H.S., LaForet, G., McIntyre, C., Martin, E.J., Chang, P., Kim, T.W., Williams, M., Reddy, P.H., Tagle, D., Boyce, F.M., Won, L., Heller, A., Aronin, N., and DiFiglia, M. (1999). Mutant huntingtin expression in clonal striatal cells: dissociation of inclusion formation and neuronal survival by caspase inhibition. J. Neurosci. 19, 964-973.
18. Künstle, G., Leist, M., Uhlig, S., Revesz, L., Feifel, R., MacKenzie, A., and Wendel, A. (1997). ICE-protease inhibitors block murine liver injury and apoptosis caused by CD95 or by TNF-α. Immunol. Lett. 55, 5-10.
19. Kuida, K., Lippke, J.A., Ku, G., Harding, M.W., Livingston, D.J., Su, M.S., and Flavell, R.A. (1995). Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science 267, 2000-2003.
20. Kuida, K., Zheng, T.S., Na, S., Kuan, C.-y., Yang, D., Karasuyama, H., Rakic, P., and Flavell, R.A. (1996). Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384, 368-372.
21. Leist, M., Gantner, F., Bohlinger, I., Tiegs, G., Germann, P.G., and Wendel, A. (1995). Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J. Pathol. 146, 1220-1234.
22. Leist, M., Single, B., Castoldi, A.F., Kühnle, S., and Nicotera, P. (1997). Intracellular ATP concentration: a switch deciding between apoptosis and necrosis. J. Exp. Med. 185, 1481-1486.
23. Levine, R.L., Oliver, C.N., Fulks, R.M., and Stadtman, E.R. (1981). Turnover of bacterial glutamine synthase: oxidative inactivation precedes proteolysis. Proc. Natl. Acad. Sci. USA 78, 2120-2125.
24. Lipton, S.A., and Rosenberg, P.A. (1994). Excitatory amino acids as a final common pathway for neurologic disorders. New Engl. J. Med. 330, 613-622.
25. Liu, X., Kim, C.N., Yang, J., Jemmerson, R., and Wang, X. (1996). Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86, 147-157.
26. Mattson, M.P. (1998). Modification of ion homeostasis by lipid peroxidation: roles in neuronal degeneration and adaptive plasticity. TINS 21, 53-57.
27. McCarthy, N.J., Whyte, M.K.B., Gilbert, C.S., and Evan, G.I. (1997). Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the bcl-2 homologue bak. J. Cell Biol. 136, 215-227.
28. Miyashita, T., Matsui, J., Ohtsuka, Y., Mami, U., Fujishima, S., Okamura-Oho, Y., Inoue, T., and Yamada, M. (1999). Expression of extended polyglutamine sequentially activates initiator and effector caspases. Biochem. Biophys. Res. Commun. 257, 724-730.
29. Nicholson, D., and Thornberry, N.A. (1997). Caspases: killer proteases. Trends Biochem. 22, 299-306.
30. 2+ and the stimulation of a nonlysosomal proteolytic system. J. Biol. Chem. 261, 14628-14635.
31. Ona, V.O., Li, M., Vonsattel, J.P., Andrews, L.J., Khan, S.Q., Chung, W.M., Frey, A.S., Menon, A.S., Li, X.J., Stieg, P.E., Yuan, J., Penney, J.B., Young, A.B., Cha, J.H., and Friedlander, R.M. (1999). Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease. Nature 399, 263-267.
32. Samali, A., Zhivotovsky, B., Jones, D., Nagata, S., and Orrenius, S. (1999). Apoptosis: cell death defined by caspase activation. Cell Death & Diff. 6, 495-496.
33. Sanchez, I., Xu, C.J., Juo, P., Kakizaka, A., Blenis, J., and Yuan, J. (1999). Caspase-8 is required for cell death induced by expanded polyglutamine repeats. Neuron 22, 623-633.
34. Sarin, A., Williams, M.S., Alexander-Miller, M.A., Berzofsky, J.A., Zacharchuk, C.M., and Henkart, P.A. (1997). Target cell lysis by CTL granule exocytosis is independent of ICE/Ced-3 family proteases. Immunity 6, 209-215.
35. Saudou, F., Finkbeiner, S., Devys, D., and Greenberg, M.E. (1998). Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95, 55-66.
36. Schierle, G.S., Hansson, O., Leist, M., Nicotera, P., Widner, H., and Brundin, P. (1999). Caspase inhibition reduces apoptosis and increases survival of nigral transplants. Nat. Med. 5, 97-100.
37. Schulz, J.B., Weller, M., and Moskowitz, M.A. (1999). Caspases as treatment targets in stroke and neurodegenerative diseases. Ann. Neurol. 45, 421-429.
38. Schwartz, L.M., and Osborne, B.A. (1993). Programmed cell death, apoptosis and killer genes. Immunol. Today 14, 582-590.
39. Schwartz, L.M., Smith, S.W., Jones, M.E.E., and Osborne, B.A. (1993). Do all programmed cell deaths occur via apoptosis? Proc. Natl. Acad. Sci. USA 90, 980-984.
40. Shaham, S., and Horvitz, H.R. (1996). Developing caenorhabditis elegans neurons may contain both cell-death protective and killer activities. Genes Dev. 10, 578-591.
41. Shoubridge, E.A. (1998). Mitochondrial encephalomyopathies. Curr. Opin. Neurol. 11, 491-496.
42. Susin, S.A., Zamzami, N., Castedo, M., Daugas, E., Wang, H.-G., Geley, S., Fassy, F., Reed, J.C., and Kroemer, G. (1997). The central executioner of apoptosis: multiple connections between protease activation and mitochondria in Fas/APO-1/ CD95-and ceramide-induced apoptosis. J. Exp. Med. 186, 25-37.
43. Vercammen, D., Beyaert, R., Denecker, G., Goossens, V., Van Loo, G., Declercq, W., Grooten, J., Fiers, W., and Vandenabeele, P. (1998). Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J. Exp. Med. 187, 1477-1485.
44. Volbracht, C., Leist, M., and Nicotera, P. (1999). ATP controls neuronal apoptosis triggered by microtubule breakdown or potassium deprivation. Mol. Med. 5, 477-489.
45. Weil, M., Jacobson, M.D., Coles, H.S.R., Davies, T.J., Gardner, R.L., Raff, K.D., and Raff, M.C. (1996). Constitutive expression of the machinery for programmed cell death. J. Cell Biol. 133, 1053-1059.
46. Williams, M.S., and Henkart, P.A. (1994). Apoptotic cell death induced by intracellular proteolysis. J. Immunol. 153, 4247-4255.
47. Williams, M.S., and Henkart, P.A. (1996). Role of reactive oxygen intermediates in TCR-induced death of T cell blasts and hybridomas. J. Immunol. 157, 2395-2402.
48. Xiang, J., Chao, D.T., and Korsmeyer, S.J. (1997). BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases. Proc. Natl. Acad. Sci. USA 93, 14559-14563.
49. Yuan, J., and Horvitz, H.R. (1990). The Caenorhabditis elegans genes ced-3 and ced-4 act cell autonomously to cause programmed cell death. Develop. Biol. 138, 33-41.
50. Yuan, J., Shaham, S., Ledoux, S., Ellis, H.M., and Horvitz, H.R. (1993). The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell 75, 641-652.